Scott D. Haller, MS

Feature

Role of the ‚ÄúDogbone‚Äù Effect of Balloon-Expandable Stents: Quantitative Coronary Analysis of DUET and NIR Stent Implantation Int

08/01/2008

Michael A. Lauer , MD;

Tim A. Fischell , MD, FACC, FSCAI;

Scott D. Haller , MS;

Christoph Hehrlein , MD;

Jennifer J. DeVries ;

Amina Arab , MD;

Ann Kloostra , RN;

Malcom T. Foster , MD;

Stent implantation has made its way into widespread clinical use since improvements in stent design and stent delivery systems facilitated deployment even in coronary lesions that are difficult to access. A variety of different stent designs...

Stent implantation has made its...

08/01/2008

Journal of Invasive Cardiology

Case Report

Intragraft Nicardipine Prophylaxis to Prevent No-reflow in Triple-vessel Saphenous Vein Graft Intervention

08/01/2008

Tim A. Fischell , MD, FACC, FSCAI;

Scott D. Haller , MS;

Kamal Ashraf , MD;

No-reflow, or slow-reflow, is a common complication during percutaneous coronary intervention in saphenous vein graft (SVG) angioplasty or stenting. No-reflow after SVG intervention is often associated with serious adverse clinical...

No-reflow, or slow-reflow, is a...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

‚ÄúPharmacologic‚Äù Distal Protection Using Prophylactic, Intragraft
Nicardipine to Prevent No-Reflow and Non-Q-Wave Myocardial In

08/01/2008

Scott D. Haller , MS;

Kamal Ashraf , MD;

Raviprasad G. Subraya , MD;

Benjamin Perry , MD;

Tim A. Fischell , MD, FACC, FSCAI;

No-reflow is a common complication during percutaneous coronary intervention in degenerated saphenous vein grafts (SVGs), and is associated with serious adverse clinical outcomes.1–6 The important role of microvascular vasoconstriction as a...

No-reflow is a common...

08/01/2008

Journal of Invasive Cardiology